de Sousa Eduardo Branco, Casado Priscila Ladeira, Moura Neto Vivaldo, Duarte Maria Eugenia Leite, Aguiar Diego Pinheiro
Stem Cell Res Ther. 2014 Oct 3;5(5):112. doi: 10.1186/scrt501.
Mesenchymal stem cells (MSCs) have the ability to differentiate into osteoblasts, chondroblasts, adipocytes, and even myoblasts. Most studies have focused on finding MSCs in different parts of the body for medical treatment. Every joint structure, including bone, joint fat, articular cartilage, and synovium, potentially contains resident MSCs. Recently, a progenitor cell population has been found in synovial fluid and showed similarities with both bone marrow and synovial membrane MSCs. Synovial fluid MSCs have been studied in healthy persons and osteoarthritic patients in order to explore its potential for treatment of some orthopedic disorders. Here, we briefly review the current knowledge on synovial fluid MSCs, their origin, relation to some orthopedic diseases, and future applications.
间充质干细胞(MSCs)具有分化为成骨细胞、软骨细胞、脂肪细胞甚至成肌细胞的能力。大多数研究都集中在寻找身体不同部位的间充质干细胞用于医学治疗。每个关节结构,包括骨骼、关节脂肪、关节软骨和滑膜,都可能含有驻留的间充质干细胞。最近,在滑液中发现了一种祖细胞群体,它与骨髓和滑膜间充质干细胞都有相似之处。为了探索其治疗某些骨科疾病的潜力,已经对健康人和骨关节炎患者的滑液间充质干细胞进行了研究。在此,我们简要回顾一下目前关于滑液间充质干细胞的知识、它们的起源、与某些骨科疾病的关系以及未来的应用。